Systematic benefit-risk assessment for the use of chloroquine or hydroxychloroquine as a treatment for COVID-19: Establishing a framework for rapid decision-making
View ORCID ProfileVicki Osborne, Miranda Davies, Sandeep Dhanda, Debabrata Roy, Samantha Lane, Alison Evans, Saad Shakir
doi: https://doi.org/10.1101/2020.05.07.20093989
Vicki Osborne
1Drug Safety Research Unit’ Southampton’ UK
2School of Pharmacy and Biomedical Sciences’ University of Portsmouth’ Portsmouth’ UK
PhDMiranda Davies
1Drug Safety Research Unit’ Southampton’ UK
2School of Pharmacy and Biomedical Sciences’ University of Portsmouth’ Portsmouth’ UK
BMSandeep Dhanda
1Drug Safety Research Unit’ Southampton’ UK
2School of Pharmacy and Biomedical Sciences’ University of Portsmouth’ Portsmouth’ UK
MB ChB MScDebabrata Roy
1Drug Safety Research Unit’ Southampton’ UK
2School of Pharmacy and Biomedical Sciences’ University of Portsmouth’ Portsmouth’ UK
PhDSamantha Lane
1Drug Safety Research Unit’ Southampton’ UK
2School of Pharmacy and Biomedical Sciences’ University of Portsmouth’ Portsmouth’ UK
MScAlison Evans
1Drug Safety Research Unit’ Southampton’ UK
2School of Pharmacy and Biomedical Sciences’ University of Portsmouth’ Portsmouth’ UK
PhDSaad Shakir
1Drug Safety Research Unit’ Southampton’ UK
2School of Pharmacy and Biomedical Sciences’ University of Portsmouth’ Portsmouth’ UK
MB ChB LRCP&S FRCP FFPM FISPE MRCGPData Availability
Data used in this analysis are available from the references supplied.
Posted May 12, 2020.
Systematic benefit-risk assessment for the use of chloroquine or hydroxychloroquine as a treatment for COVID-19: Establishing a framework for rapid decision-making
Vicki Osborne, Miranda Davies, Sandeep Dhanda, Debabrata Roy, Samantha Lane, Alison Evans, Saad Shakir
medRxiv 2020.05.07.20093989; doi: https://doi.org/10.1101/2020.05.07.20093989
Systematic benefit-risk assessment for the use of chloroquine or hydroxychloroquine as a treatment for COVID-19: Establishing a framework for rapid decision-making
Vicki Osborne, Miranda Davies, Sandeep Dhanda, Debabrata Roy, Samantha Lane, Alison Evans, Saad Shakir
medRxiv 2020.05.07.20093989; doi: https://doi.org/10.1101/2020.05.07.20093989
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (676)
- Anesthesia (182)
- Cardiovascular Medicine (2676)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12304)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4149)
- Geriatric Medicine (389)
- Health Economics (684)
- Health Informatics (2688)
- Health Policy (1009)
- Hematology (365)
- HIV/AIDS (859)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2068)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (252)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1128)
- Primary Care Research (461)
- Public and Global Health (6572)
- Radiology and Imaging (1418)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)